Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis. (1st September 2020)
- Record Type:
- Journal Article
- Title:
- Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis. (1st September 2020)
- Main Title:
- Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis
- Authors:
- Della Corte, Luigi
Barra, Fabio
Mercorio, Antonio
Evangelisti, Giulio
Rapisarda, Agnese Maria Chiara
Ferrero, Simone
Bifulco, Giuseppe
Giampaolino, Pierluigi - Abstract:
- ABSTRACT: Introduction: The second-line treatment of endometriosis-related pain symptoms includes injectable depot formulations of gonadotropin-releasing hormone analogs (GnRH-as). These drugs improve the symptomatology by inducing a hypoestrogenic status and a consequent regression of endometriotic implants. However, GnRH-a may cause a not negligible rate of adverse events, in particular vasomotor symptoms and bone mineral density loss, that may limit patients' adherence and safety on long-term treatment. Several strategies have been suggested to improve the compliance to treatment. Areas covered: This narrative review aims to give an overview of the safety and tolerability of GnRH-a therapy and to present the different options of steroidal and non-steroidal add-back therapies in order to reduce the hypoestrogenic side effects. Expert opinion: Side effects of long term GnRH-a treatment are particularly relevant. Although it has been known the efficacy of GnRH-as for treating endometriosis-associated pain, the best schedules of therapy in terms of duration and dosages are still to be defined. The ideal treatment schedule of GnRH-a is still a matter of debate as to the optimal add-back combination.
- Is Part Of:
- Expert opinion on drug metabolism and toxicology. Volume 16:Number 9(2020)
- Journal:
- Expert opinion on drug metabolism and toxicology
- Issue:
- Volume 16:Number 9(2020)
- Issue Display:
- Volume 16, Issue 9 (2020)
- Year:
- 2020
- Volume:
- 16
- Issue:
- 9
- Issue Sort Value:
- 2020-0016-0009-0000
- Page Start:
- 759
- Page End:
- 768
- Publication Date:
- 2020-09-01
- Subjects:
- Endometriosis -- hormonal therapy -- gonadotropin-releasing hormone analogs -- add-back therapy -- norethisterone acetate -- combined oral contraceptives -- bone mineral density -- vasomotor symptoms
Drugs -- Toxicology -- Periodicals
Drugs -- Metabolism -- Periodicals
615.7 - Journal URLs:
- http://www.tandfonline.com/loi/iemt20#.VxdRulL2aic ↗
http://www.expertopin.com/loi/emt ↗
http://www.ingentaconnect.com/content/apl/emt ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/17425255.2020.1789591 ↗
- Languages:
- English
- ISSNs:
- 1742-5255
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002943
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22950.xml